PHYTONADIONE

Post-LOE

phytonadione

Gen Pharmaceuticals

ANDAORALTABLET

Approved

Jul 2023

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

PHYTONADIONE (phytonadione) by Gen Pharmaceuticals is naturally-occurring vitamin k, which is necessary for the production via the liver of active prothrombin (factor ii), proconvertin (factor vii), plasma thromboplastin component (factor ix), and stuart factor (factor x). Approved for interference with vitamin k activity: anticoagulant-induced prothrombin deficiency caused by coumarin, indanedione derivatives, ulcerative colitis. First approved in 2023.

Drug data last refreshed 18h ago

Mechanism of Action

naturally-occurring vitamin K, which is necessary for the production via the liver of active prothrombin (factor II), proconvertin (factor VII), plasma thromboplastin component (factor IX), and Stuart factor (factor X). The prothrombin test is sensitive to the levels of three of these four factors…

Pharmacologic Class:

Vitamin K

Indications (3)

interference with vitamin K activity: Anticoagulant-induced prothrombin deficiency caused by coumarin

Worked on PHYTONADIONE at Gen Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.